U.S. Markets open in 36 hrs, 53 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low | 19.01 | |
|---|---|---|
| Day High 03:38 PM EDT | 22.21 |
|
| Range | 3.20 | |
| Volume | 2.56 M | |
| 30-Day Avg. Vol. | 860,000 |
|
| Difference | 198.22% | |
| Market Cap. | 1.21 B | |
| Change | 116.98 M | |
| Shares Out. | 55.18 M | |
| Percent Traded | 4.65% | |
| Revenue (LFY) | 964.28 M | |
| Earnings (TTM) | 64.64 M | |
| Next Earnings | 01/19/2009 |
|
| EPS (TTM) | 1.12 |
| 52-Wk Low | 19.01 | |
|---|---|---|
| 52-Wk High 8/11/08 | 36.16 |
|
| Range | 17.15 | |
| Prev. Close 10/9/08 | 19.98 | |
| Today's Open | 19.56 | |
| Change | -2.10% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.0395 | |
| P/E Ratio (TTM) | 19.73 | |
| P/E Ratio (Fwd.) | — |
PAREXEL International excels in biopharmaceuticals. A top contract research organization (CRO), the firm counts among its clients some of the world's largest drug, biotech, and medical device firms. Its ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.219 3/31/08 | 0.24 3/31/08 |
0.021
Beat
|
| Last Quarter | 0.257 6/30/08 | 0.28 6/30/08 |
0.023
Beat
|
| Quarterly - 06/30/2008 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 331.93 M | 964.28 M |
| Gross Profit | 86.96 M | 297.20 M |
| Operating Income | 26.94 M | 85.81 M |
| Net Income | 25.04 M | 64.64 M |
